XML 63 R55.htm IDEA: XBRL DOCUMENT v3.23.3
Restatement of Current Period (Details) - Schedule of Condensed Consolidated Statement of Stockholders’ Equity - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2022
Mar. 31, 2022
Jun. 30, 2022
Previously Reported [Member]      
Restatement of Current Period (Details) - Schedule of Condensed Consolidated Statement of Stockholders’ Equity [Line Items]      
Balance $ 170,437 $ 137,424 $ 137,424
Stock-based compensation 940 953  
Issuance of Common Stock and warrants in private placement   25,797  
Issuance of debt and warrants in private placement   13,230  
Acquisition of Lab Society   1,903  
Exercise of options 10 10  
Exercise of warrants 1 1  
Net loss (93,398) (8,881) (102,279)
Balance 77,990 170,437 77,990
Previously Reported [Member] | Common Stock [Member]      
Restatement of Current Period (Details) - Schedule of Condensed Consolidated Statement of Stockholders’ Equity [Line Items]      
Balance $ 25 $ 21 $ 21
Balance (in Shares) 26,542,890 22,207,103 22,207,103
Issuance of Common Stock and warrants in private placement   $ 2  
Issuance of Common Stock and warrants in private placement (in Shares)   2,450,350  
Acquisition of Lab Society (in Shares)   297,929  
Exercise of options (in Shares) 4,286 4,220  
Exercise of warrants   $ 2  
Exercise of warrants (in Shares) 44,254 1,583,288  
Balance $ 25 $ 25 $ 25
Balance (in Shares) 26,591,430 26,542,890 26,591,430
Previously Reported [Member] | Additional Paid-in Capital [Member]      
Restatement of Current Period (Details) - Schedule of Condensed Consolidated Statement of Stockholders’ Equity [Line Items]      
Balance $ 237,903 $ 196,013 $ 196,013
Stock-based compensation 940 953  
Issuance of Common Stock and warrants in private placement   25,795  
Issuance of debt and warrants in private placement   13,230  
Acquisition of Lab Society   1,903  
Exercise of options 10 10  
Exercise of warrants 1 (1)  
Balance 238,854 237,903 238,854
Previously Reported [Member] | Retained Earnings [Member]      
Restatement of Current Period (Details) - Schedule of Condensed Consolidated Statement of Stockholders’ Equity [Line Items]      
Balance (67,857) (58,975) (58,975)
Net loss (93,401) (8,882)  
Balance (161,258) (67,857) (161,258)
Previously Reported [Member] | Total Stockholders’ Equity attributable to Agrify [Member]      
Restatement of Current Period (Details) - Schedule of Condensed Consolidated Statement of Stockholders’ Equity [Line Items]      
Balance 170,071 137,059 137,059
Stock-based compensation 940 953  
Issuance of Common Stock and warrants in private placement   25,797  
Issuance of debt and warrants in private placement   13,230  
Acquisition of Lab Society   1,903  
Exercise of options 10 10  
Exercise of warrants 1 1  
Net loss (93,401) (8,882)  
Balance 77,621 170,071 77,621
Previously Reported [Member] | Noncontrolling Interest [Member]      
Restatement of Current Period (Details) - Schedule of Condensed Consolidated Statement of Stockholders’ Equity [Line Items]      
Balance 366 365 365
Net loss 3 1  
Balance 369 366 369
Restated [Member]      
Restatement of Current Period (Details) - Schedule of Condensed Consolidated Statement of Stockholders’ Equity [Line Items]      
Balance 156,872 137,424 137,424
Stock-based compensation 940 953  
Issuance of Common Stock and warrants in private placement   14,800  
Acquisition of Lab Society   1,903  
Exercise of options 10 10  
Exercise of warrants 1 1  
Net loss (74,601) 1,781 (72,820)
Balance $ 83,222 $ 156,872 $ 83,222
Restated [Member] | Common Stock [Member]      
Restatement of Current Period (Details) - Schedule of Condensed Consolidated Statement of Stockholders’ Equity [Line Items]      
Balance (in Shares) 132,714 111,035 111,035
Issuance of Common Stock and warrants in private placement (in Shares)   12,252  
Acquisition of Lab Society (in Shares)   1,490  
Exercise of options (in Shares) 21 21  
Exercise of warrants (in Shares) 222 7,916  
Balance (in Shares) 132,957 132,714 132,957
Restated [Member] | Additional Paid-in Capital [Member]      
Restatement of Current Period (Details) - Schedule of Condensed Consolidated Statement of Stockholders’ Equity [Line Items]      
Balance $ 213,701 $ 196,034 $ 196,034
Stock-based compensation 940 953  
Issuance of Common Stock and warrants in private placement   14,800  
Acquisition of Lab Society   1,903  
Exercise of options 10 10  
Exercise of warrants 1 1  
Net loss   0  
Balance 214,652 213,701 214,652
Restated [Member] | Retained Earnings [Member]      
Restatement of Current Period (Details) - Schedule of Condensed Consolidated Statement of Stockholders’ Equity [Line Items]      
Balance (57,195) (58,975) (58,975)
Net loss (74,604) 1,780  
Balance (131,799) (57,195) (131,799)
Restated [Member] | Total Stockholders’ Equity attributable to Agrify [Member]      
Restatement of Current Period (Details) - Schedule of Condensed Consolidated Statement of Stockholders’ Equity [Line Items]      
Balance 156,506 137,059 137,059
Stock-based compensation 940 953  
Issuance of Common Stock and warrants in private placement   14,800  
Acquisition of Lab Society   1,903  
Exercise of options 10 10  
Exercise of warrants 1 1  
Net loss (74,604) 1,780  
Balance 82,853 156,506 82,853
Restated [Member] | Noncontrolling Interest [Member]      
Restatement of Current Period (Details) - Schedule of Condensed Consolidated Statement of Stockholders’ Equity [Line Items]      
Balance 366 365 365
Net loss 3 1  
Balance $ 369 $ 366 $ 369